E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness
Authors:
Open Access
- 24 December 2018
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 110 (3) , 1085-1095
Abstract
Ovarian cancer is the most lethal cancer of the female reproductive system. In that regard, several epidemiological studies suggest that long‐term exposure to estrogen could increase ovarian cancer risk, although its precise role remains controversial. To decipher a mechanism for this, we previously generated a mathematical model of how estrogen‐mediated upregulation of the transcription factor, E2F6, upregulates the ovarian cancer stem/initiating cell marker, c‐Kit, by epigenetic silencing the tumor suppressor miR‐193a, and a competing endogenous (ceRNA) mechanism. In this study, we tested that previous mathematical model, showing that estrogen treatment of immortalized ovarian surface epithelial cells upregulated both E2F6 and c‐KIT, but downregulated miR‐193a. Luciferase assays further confirmed that microRNA‐193a targets both E2F6 and c‐Kit. Interestingly, ChIP‐PCR and bisulphite pyrosequencing showed that E2F6 also epigenetically suppresses miR‐193a, through recruitment of EZH2, and by a complex ceRNA mechanism in ovarian cancer cell lines. Importantly, cell line and animal experiments both confirmed that E2F6 promotes ovarian cancer stemness, whereas E2F6 or EZH2 depletion derepressed miR‐193a, which opposes cancer stemness, by alleviating DNA methylation and repressive chromatin. Finally, 118 ovarian cancer patients with miR‐193a promoter hypermethylation had poorer survival than those without hypermethylation. These results suggest that an estrogen‐mediated E2F6 ceRNA network epigenetically and competitively inhibits microRNA‐193a activity, promoting ovarian cancer stemness and tumorigenesis.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (102‐2320‐B‐194‐006, 103‐2320‐B‐194‐002, 104‐2115‐M‐194 ‐011‐MY3, 104‐2115‐M‐194‐009, 104‐2320‐B‐194‐003, 105‐2115‐M‐194‐009, 107‐2115‐M‐007‐011‐MY2)
This publication has 40 references indexed in Scilit:
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signalingOncogene, 2012
- Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcomeExperimental and Molecular Pathology, 2011
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cellsToxicology and Applied Pharmacology, 2010
- Epigenetic modifications as therapeutic targetsNature Biotechnology, 2010
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biologyNature, 2010
- Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissuesProceedings of the National Academy of Sciences, 2010
- Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancerBritish Journal of Cancer, 2010
- Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistantBritish Journal of Cancer, 2010